Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-31,673
Closed -$1.96M 86
2016
Q4
$1.96M Sell
31,673
-8,483
-21% -$501K 0.23% 46
2016
Q3
$2.17M Sell
40,156
-9,383
-19% -$473K 0.27% 45
2016
Q2
$2.26M Sell
49,539
-10,037
-17% -$490K 0.27% 46
2016
Q1
$2.93M Sell
59,576
-16,907
-22% -$719K 0.35% 42
2015
Q4
$3.07M Sell
76,483
-14,310
-16% -$657K 0.38% 40
2015
Q3
$4.67M Buy
90,793
+15,278
+20% +$1.01M 0.6% 34
2015
Q2
$6M Buy
75,515
+305
+0.4% +$25.8K 0.72% 33
2015
Q1
$6.18M Buy
75,210
+34,162
+83% +$2.86M 0.73% 34
2014
Q4
$3.64M Buy
41,048
+33,306
+430% +$3.02M 0.42% 37
2014
Q3
$759K Buy
+7,742
New +$870K 0.09% 58

Other funds holding ENOV

E.S. Barr & Co's ENOV Position: Q1 2017 in Review

E.S. Barr & Co sold out of Enovis (ENOV) in Q1 2017, closing a stake of 31,673 shares — an estimated $1.96M sold.

E.S. Barr & Co first reported a position in ENOV in Q3 2014 and held it in 10 quarters. The position peaked at $6.18M in Q1 2015. 218 funds tracked by Wall St. Rank hold ENOV as of Q1 2017.

  • E.S. Barr & Co reported no remaining Enovis position as of Q1 2017 after selling out during the quarter.
  • E.S. Barr & Co sold 31,673 Enovis shares in Q1 2017, an estimated $1.96M.
  • E.S. Barr & Co first reported a position in Enovis in Q3 2014 and held it in 10 quarters.
  • E.S. Barr & Co's Enovis position peaked at $6.18M in Q1 2015.
  • 218 funds tracked by Wall St. Rank held Enovis as of Q1 2017.

Based on E.S. Barr & Co's 13F filing for Q1 2017, filed 15 May 2017.